ANI PHARMACEUTICALS, INC
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $1.3M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $13.7M |
| SG&A Expense | $5.4M |
| Operating Income | $-47.4M |
| Operating Margin | -3,769.8% |
| Interest Expense | $147.0K |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-47.5M |
| Net Margin | -3,777.9% |
| EPS (Basic) | $-0.70 |
| EPS (Diluted) | $-0.70 |
| Shares Outstanding (Basic) | 67.9M |
| Shares Outstanding (Diluted) | 67.9M |
| Dividends Per Share | — |